News

Dr. Reddy’s Laboratories announces the launch of Lamotrigine Orally Disintegrating Tablets in the U.S. Market

Dr.-Reddy

Dr. Reddy’s Laboratories Ltd announced today that it has launched Lamotrigine Orally Disintegrating Tablets in 25 mg, 50 mg, 100 mg, and 200 mg, a therapeutic equivalent generic version of Lamictal ODT (lamotrigine) Orally Disintegrating Tablets in the United States market approved by the U.S. Food & Drug Administration (USFDA).

The Lamictal ODT brand and generic had U.S. sales of Dr.-Reddyapproximately $65.5 million MAT for the most recent twelve months ending in July 2016 according to IMS Health.

Dr. Reddy’s Lamotrigine Orally Disintegrating Tablets 25 mg, 50 mg, 100 mg, and 200 mg are available in bottle count sizes of 30’s.

Lamictal ODT is a registered trademark of GSK group of companies.

 

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn2Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Most Popular

To Top